Rentokil Initial steadies after analyst repricing, shares track FTSE 100 sector peers
Veröffentlicht: 26.06.2026 um 10:41 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 10:35.
Rentokil Initial (GB00B082RF11) opens Friday trade in London with a stable share price picture and a clear position in the FTSE 100’s business services segment. The group combines a moderate dividend yield with a busy analyst roster, providing a structured lens for retail investors.
What recent data show
On the London Stock Exchange, Rentokil Initial shares recently changed hands around 435.20 pence, with day highs above 440 pence and lows just over 434 pence, according to Davy’s latest quote. This places the stock close to its one-day range while remaining within a broader 52-week corridor between roughly 335 pence and 507 pence.
MarketBeat data indicate a market capitalization of about ÂŁ10.9 billion and a price-to-earnings ratio near 23.4, signaling a valuation that reflects the stability of route-based services and recurring contracts. The same source shows a dividend yield around 2.15 percent, anchored by an ex-dividend date on 9 April 2026 and a dividend pay date on 18 May 2026.
Analyst stance on the stock
Analysts tracked by MarketBeat collectively assign Rentokil Initial a "Moderate Buy" consensus rating, with an average price target of approximately 475.71 pence, pointing to measured upside from current levels. Recent commentary includes UBS reiterating a Buy rating in April 2026, underlining continued support from a major research house. At the same time, the shares have experienced periods of repricing, including a noted surge after a Jefferies upgrade to Buy in March 2026 as highlighted by Investing.com.
AmericanBankingNews reported that the stock has recently traded below its 200-day moving average, a technical signal that investors watch for momentum shifts. This move below the 200-day line aligns with a more cautious tone in parts of the market, even as the fundamental business remains rooted in multi-year customer contracts and geographic diversification.
More news and data on the Rentokil Initial shares
Further company announcements, price data and background on Rentokil Initial can be found in the ad-hoc-news topic channel and in the group’s own investor relations section.
The service portfolio behind the shares
Rentokil Initial’s core business revolves around route-based hygiene and pest control services for commercial customers across North America, the U.K., continental Europe and Asia-Pacific. In pest control, the company offers integrated pest management solutions, including regular inspection, prevention and treatment programs for sectors such as food processing, hospitality and retail.
Alongside pest control, the group operates a substantial hygiene division, supplying and servicing washroom products, hand hygiene dispensers and odor control systems for corporate and public sector clients. These services are generally delivered under contract, providing recurring revenue streams and visibility over cash flows.
Where the Rentokil Initial shares trade today
The Rentokil Initial shares (GB00B082RF11) trade on the London Stock Exchange at around 435.20 pence as of 2026-06-26, 05:40, based on the latest delayed quote from Davy. This level reflects a price that is modestly below the recent day high and within the established 52-week range noted by MarketBeat.
Key data on the Rentokil Initial shares
- Company: Rentokil Initial plc
- ISIN: GB00B082RF11
- WKN: B082RF
- Ticker: RTO
- Trading venue: London Stock Exchange
- Price (as of 2026-06-26, 05:40): 435.20 GBX
- Market cap: 10.91 billion GBP (as of 2026-06-25)
- Sector / industry: Business Services / Commercial Services
- Index membership: FTSE 100
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell any financial instrument, or a solicitation of any transaction. Prices and data are subject to change; investors should consult official sources and consider their own financial situation before making decisions.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
